News
MERCK has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than US$3 billion, the Financial Times ...
Home-grown start-up Mirxes is going places, but co-founder is firmly rooted in Singapore. Read more at straitstimes.com. Read ...
4d
theAsianparent on MSNSMART and KKH Develop First-of-Its-Kind Device (BLIPI) to Profile Newborns’ Immune FunctionIn a revolutionary leap for neonatal healthcare, researchers from the Critical Analytics for Manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results